BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7192426)

  • 1. The rediscovery of DON (6-diazo-5-oxo-L-norleucine).
    Kisner DL; Catane R; Muggia FM
    Recent Results Cancer Res; 1980; 74():258-63. PubMed ID: 7192426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
    Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
    Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diazo-oxo-norleucine on cell kinetics and odontoblast differentiation in cultured embryonic mouse molars.
    Olive M; Ruch JV
    Arch Oral Biol; 1982; 27(6):505-11. PubMed ID: 6956264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus and vesicular stomatitis virus replication in the presence of 6-diazo-5-oxo-L-norleucine or 2-deoxy-D-glucose.
    Goldstein G; Guskey LE
    J Med Virol; 1984; 14(2):159-67. PubMed ID: 6208320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of morphogenetic cell interactions by 6-diazo-5-oxo-norleucine (DON).
    Ekblom P; Lash JW; Lehtonen E; Nordling S; Saxén L
    Exp Cell Res; 1979 Jun; 121(1):121-6. PubMed ID: 446523
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro cartilage formation: effects of 6-diazo-5-oxo-L-norleucine (DON) on glycosaminoglycan and collagen synthesis.
    Linsenmayer TF; Kochhar DM
    Dev Biol; 1979 Apr; 69(2):517-28. PubMed ID: 437352
    [No Abstract]   [Full Text] [Related]  

  • 11. Diazo-oxo-norleucine (DON)-induced alterations in the extracellular matrix of the mouse tooth germ.
    Hurmerinta K; Thesleff I
    Cell Differ; 1982 Apr; 11(2):107-13. PubMed ID: 7066992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal development. V. Treatment of five-day-old embryos of domestic fowl with 6-diazo-5-oxo-L-norleucine (DON).
    Coulombre J; Coulombre A
    Dev Biol; 1975 Aug; 45(2):291-303. PubMed ID: 1193300
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
    Shapiro RA; Clark VM; Curthoys NP
    J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
    Greene RM; Kochhar DM
    J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence of an unusual tubular organelle in surface epithelial cells of the mouse ascending colon after injection of diazo-oxo-norleucine.
    Michaels JE
    Anat Rec; 1980 Aug; 197(4):413-20. PubMed ID: 7212294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
    Kaufman ER
    Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 6-diazo-5-oxo-L-norleucine, a glutamine analogue, on the structure of the major cartilage proteoglycan synthesized by cultured chondrocytes.
    Clark CC; Richards CF; Pacifici M; Iozzo RV
    J Biol Chem; 1987 Jul; 262(21):10229-38. PubMed ID: 3112139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by diazo-oxo-norleucine (DON) of rat palatal glycoproteins synthesis and epithelial cell adhesion in vitro.
    Greene RM; Pratt RM
    Exp Cell Res; 1977 Mar; 105(1):27-37. PubMed ID: 837996
    [No Abstract]   [Full Text] [Related]  

  • 19. The occurrence of an unusual tubular organelle in surface epithelial cells of the mouse ascending colon after injection of diazo-oxo-norleucine.
    Michaels JE
    Anat Rec; 1980; 196(4):413-20. PubMed ID: 7396231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of 6-diazo-5-oxo-L-norleucine, antagonist of gamma-glutamyl transpeptidase, on replication of human parainfluenza virus type 2.
    Nishio M; Tsurudome M; Bando H; Komada H; Ito Y
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():61-7. PubMed ID: 1968085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.